Mustang Bio, Inc.
USD0.68
-0.02 (-2.17%)
CEO
Manuel Litchman
IPO Date
2017-08-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.66
Prev. Close
$0.70
Day Low
$0.66
Day High
$0.70
52W Low
$0.53
52W High
$7.00
Market Cap
$0.01B
Volume
0.01M
| -3.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -41952.8% | -290.8% | 20.31 | 0.74 | -11.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -167.5% | -83.9% | 0.68 | 5.22 | -26.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -59.0% | -53.0% | 0.02 | 10.33 | -109.9 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -61.0% | -54.6% | 0.02 | 10.46 | -165.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -93.2% | -65.6% | 0.30 | 8.12 | -152.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -84.2% | -71.7% | 0.00 | 6.25 | -129.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -52.3% | -49.3% | 0.00 | 16.99 | -483.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -52.1% | -46.0% | 0.01 | 8.53 | -1015.8 |
| -3.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -4.8% | -2.4% | 0.00 | 2.05 | -5.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -26.3% | -5.8% | 0.00 | 1.30 | -1.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -4.2% | -1.0% | 0.00 | 1.34 | -11.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 24.6% | -10.2% | -0.23 | 0.68 | -20.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 16.3% | -19.6% | -0.11 | 0.40 | -18.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 98.4% | -96.2% | -0.13 | 0.46 | -6.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 105.0% | -35.6% | -0.48 | 0.53 | -28.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -7004.9% | -48.6% | 20.31 | 0.74 | -18.1 |